PBIO Stock Overview
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Pressure BioSciences, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.16 |
52 Week High | US$1.40 |
52 Week Low | US$0.14 |
Beta | -0.085 |
1 Month Change | -32.43% |
3 Month Change | -56.83% |
1 Year Change | -88.05% |
3 Year Change | -92.42% |
5 Year Change | -95.73% |
Change since IPO | -99.93% |
Recent News & Updates
Recent updates
Shareholder Returns
PBIO | US Life Sciences | US Market | |
---|---|---|---|
7D | 8.2% | -1.9% | 0.6% |
1Y | -88.0% | 3.9% | 29.5% |
Return vs Industry: PBIO underperformed the US Life Sciences industry which returned 3.4% over the past year.
Return vs Market: PBIO underperformed the US Market which returned 29.8% over the past year.
Price Volatility
PBIO volatility | |
---|---|
PBIO Average Weekly Movement | 22.5% |
Life Sciences Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PBIO's share price has been volatile over the past 3 months.
Volatility Over Time: PBIO's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1978 | 17 | Richard Schumacher | https://www.pressurebiosciences.com |
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company’s pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3.
Pressure BioSciences, Inc. Fundamentals Summary
PBIO fundamental statistics | |
---|---|
Market cap | US$4.81m |
Earnings (TTM) | -US$29.56m |
Revenue (TTM) | US$2.27m |
2.1x
P/S Ratio-0.2x
P/E RatioIs PBIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PBIO income statement (TTM) | |
---|---|
Revenue | US$2.27m |
Cost of Revenue | US$2.12m |
Gross Profit | US$156.61k |
Other Expenses | US$29.71m |
Earnings | -US$29.56m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.95 |
Gross Margin | 6.89% |
Net Profit Margin | -1,300.58% |
Debt/Equity Ratio | -73.6% |
How did PBIO perform over the long term?
See historical performance and comparison